HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

2A peptide-based, lentivirus-mediated anti-death receptor 5 chimeric antibody expression prevents tumor growth in nude mice.

Abstract
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), a member of the TNF superfamily, induces tumor cell death via death receptors on target cells, without adverse effects on most normal cells. Its receptors are therefore an attractive target for antibody-mediated tumor therapy. Here, we report the creation of a lentivirus vector constructed by linking the heavy chain and the light chain of the antibody with a 2A/furin self-processing peptide in a single open reading frame that expresses a novel chimeric antibody (named as zaptuximab) with tumoricidal activity, which is consisted of the variable region of a mouse anti-human DR5 monoclonal antibody, AD5-10, and the constant region of human immunoglobulin G1. Lentivirus-expressed zaptuximab bound specifically to its antigen, DR5, and exhibited significant apoptosis-inducing activity in various tumor cell lines. The packaged recombinant virus lenti-HF2AL showed strong apoptosis-inducing activity in vitro. Meanwhile, inoculated subcutaneous human colon HCT116 tumor formation in nude mice were inhibited significantly. Moreover, there was a synergistic effect of mitomycin C (MMC) on the observed tumoricidal efficacy, prolonging the life span of nude mice with orthotopic human lung tumor cancers. These data suggest that lentivirus-mediated, 2A peptide-based anti-DR5 chimeric antibody expression may have clinical utility as an anticancer treatment and may represent a rational adjuvant therapy in combination with chemotherapy.
AuthorsMeng Li, Yaomin Wu, Yuhe Qiu, Zhenyu Yao, Shilian Liu, Yanxin Liu, Juan Shi, Dexian Zheng
JournalMolecular therapy : the journal of the American Society of Gene Therapy (Mol Ther) Vol. 20 Issue 1 Pg. 46-53 (Jan 2012) ISSN: 1525-0024 [Electronic] United States
PMID21934654 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Immunoglobulin Heavy Chains
  • Immunoglobulin Light Chains
  • Peptides
  • Receptors, TNF-Related Apoptosis-Inducing Ligand
  • Mitomycin
  • Furin
Topics
  • Animals
  • Antibodies, Monoclonal (genetics)
  • Antibody Affinity
  • Cell Death (genetics)
  • Disease Models, Animal
  • Drug Synergism
  • Female
  • Furin (chemistry)
  • Gene Expression
  • Gene Order
  • Genetic Therapy
  • Genetic Vectors (administration & dosage, genetics)
  • HCT116 Cells
  • HEK293 Cells
  • HL-60 Cells
  • Hep G2 Cells
  • Humans
  • Immunoglobulin Heavy Chains (genetics)
  • Immunoglobulin Light Chains (genetics)
  • Lentivirus (genetics)
  • Lung Neoplasms (genetics, therapy)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Mitomycin (administration & dosage, pharmacology)
  • Neoplasms (genetics, therapy)
  • Peptides (genetics)
  • Receptors, TNF-Related Apoptosis-Inducing Ligand (antagonists & inhibitors, immunology)
  • U937 Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: